Comparison of amino acids and acylcarnitines assay methods used in newborn screening assays by tandem mass spectrometry
| Autor: | W. Harry Hannon, Donald H. Chace, Víctor R. De Jesús, Joanne V. Mei, Timothy H. Lim |
|---|---|
| Rok vydání: | 2010 |
| Předmět: |
Quality Control
Analyte Butanols Phenylalanine Clinical Biochemistry Tandem mass spectrometry Mass spectrometry Biochemistry chemistry.chemical_compound Methionine Neonatal Screening Metabolic Diseases Leucine Tandem Mass Spectrometry Carnitine Proficiency testing Humans Amino Acids Derivatization chemistry.chemical_classification Newborn screening Chromatography Biochemistry (medical) Infant Newborn Palmitoylcarnitine General Medicine Amino acid Dried blood spot chemistry |
| Zdroj: | Clinica Chimica Acta. 411:684-689 |
| ISSN: | 0009-8981 |
| DOI: | 10.1016/j.cca.2010.01.034 |
| Popis: | The analysis of amino acids (AA) and acylcarnitines (AC) by tandem mass spectrometry (MS/MS) is performed in newborn screening laboratories worldwide. While butyl esterification assays are routine, it is possible to detect AAs and ACs as their native free acids (underivatized). The Centers for Disease Control and Prevention's Newborn Screening Quality Assurance Program provides dried blood spot (DBS) quality control (QC) and proficiency testing (PT) programs for numerous MS/MS analytes. We describe empirical differences between derivatization and non-derivatization techniques for selected AAs and ACs.DBS materials were prepared at levels near, above and below mean domestic laboratory cut-offs, and distributed to program participants for MS/MS analysis. Laboratories reported quantitative and qualitative results. QC DBS materials were assayed in-house following established protocols.Minor differences (15%) between quantitative values resulting from butyl esters and free acid techniques were observed for the majority of the analytes. Mass spectrometric response from underivatized dicarboxylic acid acylcarnitines was less intense than their butyl esters.The use of underivatized techniques may also result in the inability to differentiate isobaric acylcarnitines. Laboratories should establish their own protocols by focusing on the decisions that identify test results requiring additional follow-up testing versus those that do not. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect